Stay updated with breaking news from Gary Charles Robb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as $34.39 and last traded at $34.20, with a volume of 520210 shares trading hands. The stock had previously closed at $32.87. Wall Street Analyst Weigh In A number of […]
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.03, Briefing.com reports. The firm had revenue of $135.41 million for the quarter, compared to analysts’ expectations of $129.27 million. Corcept Therapeutics […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Equities research analysts at Zacks Research cut their Q1 2024 earnings per share (EPS) estimates for Corcept Therapeutics in a report released on Thursday, February 1st. Zacks Research analyst K. Das now forecasts that the biotechnology company will post earnings of $0.05 per share for the quarter, […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) insider Gary Charles Robb sold 1,381 shares of the firm’s stock in a transaction that occurred on Tuesday, December 5th. The shares were sold at an average price of $26.27, for a total value of $36,278.87. Following the completion of the sale, the insider now directly owns […]
Pinebridge Investments L.P. purchased a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 1,378 shares of the biotechnology company’s stock, valued at approximately $31,000. Other institutional investors also recently bought […]